I

ICU Medical
D

ICUI

135.030
USD
0.56
(0.42%)
Market Closed
Volume
13,618
EPS
7
Div Yield
-
P/E
-35
Market Cap
3,323,349,853
Related Instruments
ABT
ABT
0.690
(0.52%)
133.560 USD
BAX
BAX
-0.195
(-0.64%)
30.505 USD
BDX
BDX
-1.245
(-0.72%)
172.595 USD
BMY
BMY
0.415
(0.87%)
48.265 USD
COO
COO
-11.780
(-14.72%)
68.250 USD
EW
EW
0.460
(0.59%)
78.180 USD
ISRG
ISRG
-3.67
(-0.66%)
552.04 USD
MDT
MDT
0.570
(0.69%)
82.940 USD
SYK
SYK
0.23
(0.06%)
382.48 USD
T
TFX
-0.210
(-0.17%)
122.260 USD
ZBH
ZBH
-1.170
(-1.25%)
92.180 USD
More
News

Title: ICU Medical

Sector: Healthcare
Industry: Medical Instruments & Supplies
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.